Treatment optimisation for hepatitis C in the era of combination direct-acting antiviral therapy: a systematic review and meta-analysis

Background: Prior to direct-acting antiviral (DAA) therapy, personalised medicine played an important role in the treatment of hepatitis C virus (HCV). Whilst simplified treatment strategies are central to treatment scale-up, some patients will benefit from treatment optimisation. This systematic re...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Christopher R., Flower, Barnaby F., Barber, Ella, Simmons, Bryony, Cooke, Graham S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2019
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854875/
https://www.ncbi.nlm.nih.gov/pubmed/31754636
http://dx.doi.org/10.12688/wellcomeopenres.15411.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854875/
https://www.ncbi.nlm.nih.gov/pubmed/31754636
http://dx.doi.org/10.12688/wellcomeopenres.15411.1

Ejemplares similares